PrednisolonePrednisoneGlucocorticoidsVincristineAnti-Inflammatory AgentsCyclophosphamideAzathioprineImmunosuppressive AgentsDrug Therapy, CombinationTreatment OutcomeAdministration, OralDoxorubicinMethylprednisoloneAntineoplastic Combined Chemotherapy ProtocolsDrug Administration ScheduleProcarbazineMechlorethamineCyclosporinePulse Therapy, DrugDouble-Blind MethodMelphalanMethotrexateAntibodies, Monoclonal, Murine-DerivedRemission InductionAdrenal Cortex HormonesTime FactorsChlorambucilMitoxantroneNephrotic SyndromeBell PalsyMycophenolic AcidPolymyalgia RheumaticaBleomycinFollow-Up StudiesHydrocortisoneKidney TransplantationRecurrenceLymphoma, Non-HodgkinAsparaginaseHodgkin DiseaseArthritis, RheumatoidDexamethasoneColor TherapyClinical Trials as TopicVinblastineLymphoma, Large B-Cell, DiffuseDose-Response Relationship, DrugTacrolimusThalidomideCombined Modality TherapyAntirheumatic AgentsGraft RejectionPregnenediones6-MercaptopurineMultiple MyelomaTablets, Enteric-CoatedProspective StudiesInjections, IntravenousEtoposideSurvival AnalysisRetrospective StudiesBeclomethasoneAsthmaCyclosporinsDisease-Free SurvivalSurvival RateLupus Erythematosus, SystemicPrecursor Cell Lymphoblastic Leukemia-LymphomaBetamethasoneRemission, SpontaneousHepatitis, AutoimmuneVindesineMyasthenia GravisImmunosuppressionBudesonideEnemaAntibodies, MonoclonalIsonipecotic AcidsEosinophiliaHydroxychloroquinePrognosisThrombocytopeniaLeukocyte CountGiant Cell ArteritisSarcoidosisSeverity of Illness IndexTaxoidsSulfasalazineRandom AllocationAntineoplastic Agents, HormonalAcute DiseaseColitis, UlcerativeAdministration, InhalationLymphoma, FollicularTriamcinolonePlasmapheresisInfusions, IntravenousAntineoplastic AgentsGraft SurvivalDaunorubicin